Novo Integrated Sciences Comprehensive Income 2012-2024 | NVOS

Novo Integrated Sciences comprehensive income from 2012 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Novo Integrated Sciences Annual Comprehensive Income
(Millions of US $)
2024 $1
2023 $-0
2022 $1
2021 $1
2020 $1
2019 $1
2018 $1
2017 $1
2016 $
2016 $1
2015 $
2014 $0
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Comprehensive Income
(Millions of US $)
2024-08-31 $1
2024-05-31 $1
2024-02-29 $1
2023-11-30 $-0
2023-08-31 $-0
2023-05-31 $-0
2023-02-28 $-0
2022-11-30 $0
2022-08-31 $1
2022-05-31 $1
2022-02-28 $1
2021-11-30 $1
2021-08-31 $1
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $1
2020-02-29 $1
2019-11-30 $1
2019-08-31 $1
2019-05-31 $1
2019-02-28 $1
2018-11-30 $1
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $2
2017-03-31
2017-02-28
2016-12-31
2016-11-30
2016-09-30
2016-06-30
2016-05-31
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00